Literature DB >> 15653138

Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release.

R Herrero-Vanrell1, A C Rincón, M Alonso, V Reboto, I T Molina-Martinez, J C Rodríguez-Cabello.   

Abstract

Elastin-like polymers (ELPs) are a new kind of protein-based polymers showing interesting properties in the biomaterial field. This work explored the use of self-assembled poly(VPAVG) micro- and nanoparticles as vehicles for the controlled release of the model drug dexamethasone phosphate (DMP). Poly(VPAVG) has shown to form stable particles with a size below 3 mum as a water or PBS polymer solution was warmed above its transition temperature ( approximately 30 degrees C). Due to the peculiar composition of the monomer, the formation and redissolution of the self-assembled microparticles shows an interesting hysteresis behaviour by which the particles are formed at this temperature but do not redissolve until a strong undercooling of approximately 12-15 degrees C is achieved. Therefore, the particles, once formed, are stable either at room or body temperature. These self-assembled particles are able to encapsulate significant amounts of the model drug when self-assembling was carried out in a co-solution polymer-DMP. The release profiles showed a sustained DMP release for about 30 days. Being the potential of this new polymeric carrier high, further research is being conducted to functionalise the poly(VPAVG) base as a way to induce a stronger polymer-drug binding and, accordingly, a more sustained release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653138     DOI: 10.1016/j.jconrel.2004.10.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  40 in total

1.  Effects of crosslinking on the mechanical properties, drug release and cytocompatibility of protein polymers.

Authors:  Adam W Martinez; Jeffrey M Caves; Swathi Ravi; Wehnsheng Li; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-08-29       Impact factor: 8.947

2.  Maleimide-thiol coupling of a bioactive peptide to an elastin-like protein polymer.

Authors:  Swathi Ravi; Venkata R Krishnamurthy; Jeffrey M Caves; Carolyn A Haller; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2011-10-25       Impact factor: 8.947

3.  Polymer-Based Therapeutics.

Authors:  Shuang Liu; Ronak Maheshwari; Kristi L Kiick
Journal:  Macromolecules       Date:  2009-01-13       Impact factor: 5.985

4.  In vitro and in vivo imaging of peptide-encapsulated polymer nanoparticles for cancer biomarker activated drug delivery.

Authors:  Gulsim K Kulsharova; Matthew B Lee; Felice Cheng; Munima Haque; Hyungsoo Choi; Kyekyoon Kim; William D O'Brien; G Logan Liu
Journal:  IEEE Trans Nanobioscience       Date:  2013-12       Impact factor: 2.935

Review 5.  Designing protein-based biomaterials for medical applications.

Authors:  Jennifer E Gagner; Wookhyun Kim; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

6.  Molecular model of human tropoelastin and implications of associated mutations.

Authors:  Anna Tarakanova; Giselle C Yeo; Clair Baldock; Anthony S Weiss; Markus J Buehler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-26       Impact factor: 11.205

Review 7.  Recombinant elastin-mimetic biomaterials: Emerging applications in medicine.

Authors:  Wookhyun Kim; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2010-05-02       Impact factor: 15.470

8.  Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying.

Authors:  Yiquan Wu; J Andrew MacKay; Jonathan R McDaniel; Ashutosh Chilkoti; Robert L Clark
Journal:  Biomacromolecules       Date:  2009-01-12       Impact factor: 6.988

9.  Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.

Authors:  Daniel J Hines; David L Kaplan
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2013       Impact factor: 4.889

Review 10.  Nanoparticle-based targeted drug delivery.

Authors:  Rajesh Singh; James W Lillard
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.